Preferential in vivo action of F15599, a novel 5‐HT1A receptor agonist, at postsynaptic 5‐HT1A receptors

No abstract is available for this paper.

• Publication year

  2010

• Venue

  British Journal of Pharmacology

• Publication date

  2010-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1476-5381.2010.00738.xPMID 20649591PMCID PMC2958639
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guide to Receptors and Channels (GRAC), 5th edition

  2011cited by this paper
• [18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging

  2010cited by this paper
• F15599, a highly selective post-synaptic 5-HT(1A) receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity.

  2010cited by this paper
• Region-specific changes in 5-HT1A agonist-induced Extracellular signal-Regulated Kinases 1/2 phosphorylation in rat brain: a quantitative ELISA study.

  2009cited by this paper
• Signal transduction and functional selectivity of F15599, a preferential post‐synaptic 5‐HT1A receptor agonist

  2009cited by this paper
• Guide to Receptors and Channels (GRAC), 3rd edition

  2008cited by this paper
• Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia?

  2008cited by this paper
• The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs.

  2008influential reference
• Synthesis, fluorine-18 labelling and radiopharmacological evaluation of F15599, a novel 5-HT1A receptor agonist

  2008cited by this paper
• Boosting slow oscillations during sleep potentiates memory

  2008cited by this paper
• P.1.c.034 Postsynaptic 5-HT1A receptors are involved in the excitatory action of 8-OH-DPAT on prefrontal cortex pyramidal neurons

  2008cited by this paper
• Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine

  2007influential reference
• In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain

  2007cited by this paper
• NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons

  2007cited by this paper
• Guide to Receptors and Channels (GRAC), 2nd edition (2007 Revision).

  2007cited by this paper
• Boosting slow oscillations during sleep potentiates memory

  2006cited by this paper
• Activation of pyramidal cells in rat medial prefrontal cortex projecting to ventral tegmental area by a 5-HT1A receptor agonist.

  2006cited by this paper
• Involvement of 5-HT1A Receptors in Prefrontal Cortex in the Modulation of Dopaminergic Activity: Role in Atypical Antipsychotic Action

  2005cited by this paper
• Contrasting Contribution of 5-Hydroxytryptamine 1A Receptor Activation to Neurochemical Profile of Novel Antipsychotics: Frontocortical Dopamine and Hippocampal Serotonin Release in Rat Brain

  2005cited by this paper
• A Subpopulation of Neurons in the Medial Prefrontal Cortex Encodes Emotional Learning with Burst and Frequency Codes through a Dopamine D4 Receptor-Dependent Basolateral Amygdala Input

  2005cited by this paper
• Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex.

  2004cited by this paper
• Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA.

  2004influential reference
• Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex.

  2004cited by this paper
• Serotonin1A receptors at the axon initial segment of prefrontal pyramidal neurons in schizophrenia.

  2004cited by this paper
• Modulation of Serotonergic Function in Rat Brain by VN2222, a Serotonin Reuptake Inhibitor and 5-HT1A Receptor Agonist

  2003cited by this paper
• Is there a role for 5-HT1A agonists in the treatment of depression?

  2003influential reference
• In vivo inhibition of neuronal activity in the rat ventromedial prefrontal cortex by midbrain-raphe nuclei: role of 5-HT1A receptors.

  2003cited by this paper
• In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents.

  2003cited by this paper
• 5‐HT2A and D2 receptor blockade increases cortical DA release via 5‐HT1A receptor activation: a possible mechanism of atypical antipsychotic‐induced cortical dopamine release

  2001cited by this paper
• Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment.

  2001cited by this paper
• Differential Occupancy of Somatodendritic and Postsynaptic 5HT1A Receptors by Pindolol: A Dose-Occupancy Study with [11C]WAY 100635 and Positron Emission Tomography in Humans

  2001cited by this paper
• The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia.

  2001cited by this paper
• How does pindolol improve antidepressant action?

  2001cited by this paper
• Control of Dorsal Raphe Serotonergic Neurons by the Medial Prefrontal Cortex: Involvement of Serotonin-1A, GABAA, and Glutamate Receptors

  2001cited by this paper
• The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?

  2001cited by this paper
• Cellular and network mechanisms of rhythmic recurrent activity in neocortex

  2000cited by this paper
• Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors.

  2000influential reference
• Somatodendritic localization of 5‐HT1A and preterminal axonal localization of 5‐HT1B serotonin receptors in adult rat brain

  2000cited by this paper
• In vivo actions of the selective 5-HT1A receptor agonist BAY x 3702 on serotonergic cell firing and release

  2000cited by this paper
• 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.

  2000cited by this paper
• Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex.

  1999cited by this paper
• Electrophysiological examination of the effects of sustained flibanserin administration on serotonin receptors in rat brain

  1999cited by this paper
• Role of the medial prefrontal cortex in 5‐HT1A receptor‐induced inhibition of 5‐HT neuronal activity in the rat

  1999influential reference
• Full agonistic properties of BAY x 3702 on presynaptic and postsynaptic 5-HT1A receptors electrophysiological studies in the rat hippocampus and dorsal raphe.

  1998cited by this paper
• Long-Term Antidepressant Treatments Result in a Tonic Activation of Forebrain 5-HT1A Receptors

  1998cited by this paper
• Molecular determinants of NMDA receptor function in GABAergic neurones of rat forebrain.

  1997cited by this paper
• Functional Mapping of Dorsal and Median Raphe 5‐Hydroxytryptamine Pathways in Forebrain of the Rat Using Microdialysis

  1997cited by this paper
• Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe

  1997cited by this paper
• Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation.

  1997influential reference
• Immunocytochemical localization of serotonin1A receptors in the rat central nervous system

  1996cited by this paper
• Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

  1996cited by this paper
• BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex

  1995cited by this paper
• Differences in Ca2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression.

  1994cited by this paper
• Cloned glutamate receptors.

  1994cited by this paper
• Electrophysiological evidence for a functional interaction between 5‐HT1A and 5‐HT2A receptors in the rat medial prefrontal cortex: An lontophoretic study

  1994cited by this paper
• The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex.

  1994cited by this paper
• Thalamocortical oscillations in the sleeping and aroused brain.

  1993influential reference
• Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex.

  1993cited by this paper
• Partial agonists, full agonists, antagonists: dilemmas of definition.

  1993cited by this paper
• In Vivo Brain Dialysis Study of the Somatodendritic Release of Serotonin in the Raphe Nuclei of the Rat: Effects of 8‐Hydroxy‐2‐(Di‐n‐Propylamino)tetralin

  1993cited by this paper
• Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5‐HT1A agonists

  1993cited by this paper
• Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding

  1992cited by this paper
• 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex.

  1991cited by this paper
• Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.

  1990cited by this paper
• Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis.

  1989cited by this paper
• Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons.

  1988cited by this paper
• Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro.

  1987cited by this paper
• Pertussis toxin blocks 5-HT1A and GABAB receptor-mediated inhibition of serotonergic neurons.

  1987influential reference
• Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonists

  1987cited by this paper
• Modification of 5‐HT neuron properties by sustained administration of the 5‐HT1A agonist gepirone: Electrophysiological studies in the rat brain

  1987cited by this paper
• Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors.

  1985cited by this paper
• The rat brain in stereotaxic coordinates: Authors: George Paxinos & Charles Watson Academic Press Australia, 1982 Softback, 154 pages (including 71 plates), 35.00 Aust $

  1983cited by this paper
• Antidromically identified serotonergic neurons in the rat midbrain raphe: evidence for collateral inhibition.

  1977influential reference

• Rescue of respiratory and cognitive impairments in Rett Syndrome mice using NLX-101, a selective 5-HT1A receptor biased agonist.

  2025cites this paper
• Effects of 5-HT1A Receptor Overexpression in the Frontal Cortex on Autism-Like Behavior and the Expression of 5-HT1A and 5-HT7 Receptors and BDNF in BTBR Mice

  2025cites this paper
• Acute administration of NLX-101, a Serotonin 1A receptor agonist, improves auditory temporal processing during development in a mouse model of Fragile X Syndrome

  2025cites this paper
• Serotonin 5-HT1A receptor biased agonists: the challenge of translating an innovative neuropharmacological concept into therapeutics.

  2024cites this paper
• Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands

  2024cites this paper
• Rapid reorganization of serotonin projections and antidepressant response to 5-HT1A-biased agonist NLX-101 in fluoxetine-resistant cF1ko mice.

  2024influential citation
• Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures

  2024cites this paper
• Gα Protein Signaling Bias at Serotonin 1A Receptor

  2023cites this paper
• The Serotonin 1A (5-HT_1A) Receptor as a Pharmacological Target in Depression

  2023cites this paper
• The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, display ketamine-like RAAD and anti-TRD activities in rat CMS models

  2023influential citation
• Biased 5-HT1A receptor agonists F13714 and NLX-101 differentially affect pattern separation and neuronal plasticity in rats after acute and chronic treatment.

  2022cites this paper
• Dissecting the contribution of 5-HT1A auto- and heteroreceptors in sucrose overconsumption in mice.

  2022cites this paper
• Acute and Repeated Administration of NLX-101, a Selective Serotonin-1A Receptor Biased Agonist, Reduces Audiogenic Seizures in Developing Fmr1 Knockout Mice.

  2022cites this paper
• NLX-101, a 5-HT1A receptor-biased agonist, improves pattern separation and stimulates neuroplasticity in aged rats.

  2022cites this paper
• The 5-HT1A receptor biased agonist, NLX-204, shows rapid-acting antidepressant-like properties and neurochemical changes in two mouse models of depression.

  2022cites this paper
• Molecular Signaling Mechanisms for the Antidepressant Effects of NLX-101, a Selective Cortical 5-HT1A Receptor Biased Agonist

  2022influential citation
• NLX-101, a cortical 5-HT1A receptor biased agonist, reverses scopolamine-induced deficit in the delayed non-matching to position model of cognition.

  2021cites this paper
• Update on GPCR-based targets for the development of novel antidepressants

  2021cites this paper
• Differential effects of memory enhancing and impairing doses of methylphenidate on serotonin metabolism and 5-HT1A, GABA, glutamate receptor expression in the rat prefrontal cortex.

  2021cites this paper
• Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders.

  2021cites this paper
• Perspectives for therapy of treatment‐resistant depression

  2021influential citation
• Serotonin/dopamine interaction: Electrophysiological and neurochemical evidence.

  2021cites this paper
• P.0604 Similarly to ketamine, selective cortical 5-HT1A receptor biased agonists elicit rapid-acting antidepressant effects in the rat chronic mild stress model

  2021cites this paper
• Discriminative stimulus properties of the 5-HT1A receptor biased agonists NLX-101 and F13714, in rats trained to discriminate 8-OH-DPAT from saline

  2021cites this paper
• Serotonergic control of excitability: from neuron to networks

  2020cites this paper
• Altered monoaminergic levels, spasticity, and balance disability following repetitive blast-induced traumatic brain injury in rats.

  2020cites this paper
• The 5-HT1A receptor as a serotonergic target for neuroprotection in cerebral ischemia.

  2020cites this paper
• NLX-101, a highly selective 5-HT1A receptor biased agonist, mediates antidepressant-like activity in rats via prefrontal cortex 5-HT1A receptors.

  2020cites this paper
• Bell-shaped agonist activation of 5-HT1A receptor-coupled Gαi3 G-proteins: Receptor density-dependent switch in receptor signaling.

  2019cites this paper
• Cortical 5-hydroxytryptamine 1A receptor biased agonist, NLX-101, displays rapid-acting antidepressant-like properties in the rat chronic mild stress model

  2019influential citation
• In vivo electrophysiological recordings of the effects of antidepressant drugs

  2019cites this paper
• Novel Aryloxyethyl Derivatives of 1-(1-Benzoylpiperidin-4-yl)methanamine as the Extracellular Regulated Kinases 1/2 (ERK1/2) Phosphorylation-Preferring Serotonin 5-HT1A Receptor-Biased Agonists with Robust Antidepressant-like Activity.

  2019cites this paper
• Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson’s Disease

  2019cites this paper
• Serotonin 5-HT1A Receptor Biased Agonists Display Differential Anxiolytic Activity in a Rat Social Interaction Model.

  2019cites this paper
• Serotonin2B receptors in the rat dorsal raphe nucleus exert a GABA‐mediated tonic inhibitory control on serotonin neurons

  2019cites this paper
• Pharmacological MRI to investigate the functional selectivity of 5-HT1A receptor biased agonists.

  2019cites this paper
• From Receptor Selectivity to Functional Selectivity: The Rise of Biased Agonism in 5-HT1A Receptor Drug Discovery.

  2019cites this paper
• Review of antidepressants in clinic and active ingredients of traditional Chinese medicine targeting 5-HT1A receptors.

  2019cites this paper
• The 5-HT1A receptor: Signaling to behavior.

  2019cites this paper
• Serotonin 5-HT1A receptor biased agonists induce different cerebral metabolic responses: A [18F]FDG PET study in conscious and anesthetized rats.

  2018cites this paper
• Activation of somatodendritic 5-HT1A autoreceptors reduces the acquisition and expression of cued fear in the rat fear-potentiated startle test

  2018cites this paper
• Effects of the Serotonin 5-HT1A Receptor Biased Agonists, F13714 and F15599, on Striatal Neurotransmitter Levels Following l-DOPA Administration in Hemi-Parkinsonian Rats

  2018cites this paper
• Serotonergic targets for the treatment of l-DOPA-induced dyskinesia

  2018cites this paper
• Activity of Serotonin 5-HT1A Receptor Biased Agonists in Rat: Anxiolytic and Antidepressant-like properties.

  2018cites this paper
• Brain Circuits Regulated by the 5-HT 2A Receptor: Behavioural Consequences on Anxiety and Fear Memory

  2018cites this paper
• Serotonergic mechanisms involved in antidepressant‐like responses evoked by GLT‐1 blockade in rat infralimbic cortex

  2018cites this paper
• The antipsychotic drug brexpiprazole reverses phencyclidine-induced disruptions of thalamocortical networks.

  2017cites this paper
• Involvement of presynaptic 5‐HT1A receptors in the low propensity of brexpiprazole to induce extrapyramidal side effects in rats

  2017influential citation
• Characterization of structurally novel G protein biased CB1 agonists: Implications for drug development

  2017cites this paper
• Characterizing the differential roles of striatal 5‐HT1A auto‐ and hetero‐receptors in the reduction of l‐DOPA‐induced dyskinesia

  2017influential citation
• Functional selectivity – chance for better and safer drugs?

  2017cites this paper
• Role of the infralimbic cortex in depression: Functional connectivity and behavioral phenotypes

  2017cites this paper
• [Pharmacological properties of vortioxetine and its pre-clinical consequences].

  2016cites this paper
• Selective serotonin 5-HT1A receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI study

  2016cites this paper
• Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.

  2016cites this paper
• Common Mechanisms Underlying Epileptogenesis and the Comorbidities of Epilepsy.

  2016cites this paper
• The role of 5-HT1A and 5-HT1B receptors in MDMA self-administration

  2016cites this paper
• Serotonin and inhibitory response control: focusing on the role of 5-HT(1A) receptors.

  2015cites this paper
• Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.

  2015cites this paper
• The highly-selective 5-HT(1A) agonist F15599 reduces L-DOPA-induced dyskinesia without compromising anti-parkinsonian benefits in the MPTP-lesioned macaque.

  2015cites this paper
• Depression und Epilepsie

  2015cites this paper
• Developments in the field of antidepressants, where do we go now?

  2015cites this paper
• New insight into the therapeutic role of the serotonergic system in Parkinson's disease.

  2015cites this paper
• Unraveling the modulatory actions of serotonin on male rat sexual responses.

  2015cites this paper
• Serotonergic Regulation of Prefrontal Cortical Circuitries Involved in Cognitive Processing: A Review of Individual 5-HT Receptor Mechanisms and Concerted Effects of 5-HT Receptors Exemplified by the Multimodal Antidepressant Vortioxetine.

  2015cites this paper
• Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity. Part 4.

  2015cites this paper
• 5-HT1A Receptor Agonist Befiradol Reduces Fentanyl-induced Respiratory Depression, Analgesia, and Sedation in Rats

  2015cites this paper
• Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands

  2015cites this paper
• Genetic Variations in the Serotonergic System Mediate a Combined, Weakened Response to SSRI Treatment: A Proposed Model,

  2015cites this paper
• Anti-aggressive effects of the selective high-efficacy ‘biased’ 5-HT1A receptor agonists F15599 and F13714 in male WTG rats

  2015cites this paper
• The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs.

  2014cites this paper
• Biomarkers of Epileptogenesis: Psychiatric Comorbidities (?)

  2014cites this paper
• Cognitive Enhancers (Nootropics). Part 1: Drugs interacting with Receptors. Update 2014

  2014cites this paper
• Omega-3 fatty acid deficient male rats exhibit abnormal behavioral activation in the forced swim test following chronic fluoxetine treatment: association with altered 5-HT1A and alpha2A adrenergic receptor expression.

  2014cites this paper
• Serotonin-prefrontal cortical circuitry in anxiety and depression phenotypes: pivotal role of pre- and post-synaptic 5-HT1A receptor expression

  2014cites this paper
• Pinpointing brainstem mechanisms responsible for autonomic dysfunction in Rett syndrome: therapeutic perspectives for 5-HT1A agonists

  2014cites this paper
• Serotonin 1A auto‐receptors are not sufficient to modulate anxiety in mice

  2013cites this paper
• 5-HT(1A) receptors direct the orientation of plasticity in layer 5 pyramidal neurons of the mouse prefrontal cortex.

  2013cites this paper
• Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction

  2013cites this paper
• D(1) receptor agonists reverse the subchronic phencyclidine (PCP)-induced novel object recognition (NOR) deficit in female rats.

  2013cites this paper
• A selective 5-HT 1 a receptor agonist improves respiration in a mouse model of Rett syndrome

  2013cites this paper
• Development of novel serotonin 5-HT6 and dopamine D2 receptor ligands and MAO A inhibitors - Synthesis, structure-activity relationships and pharmacological characterization

  2013cites this paper
• Dopamine neurotransmission and atypical antipsychotics in prefrontal cortex: a critical review.

  2013cites this paper
• Facilitative effect of serotonin(1A) receptor agonists on cognition in patients with schizophrenia.

  2013cites this paper
• A selective 5-HT1a receptor agonist improves respiration in a mouse model of Rett syndrome.

  2013cites this paper
• Serotonin modulation of cortical neurons and networks

  2013cites this paper
• Future directions for serotonin and antidepressants.

  2013cites this paper
• Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of Research

  2013cites this paper
• Aggression-reducing effects of F15599, a novel selective 5-HT1A receptor agonist, after microinjection into the ventral orbital prefrontal cortex, but not in infralimbic cortex in male mice

  2013cites this paper
• Serotonin receptors involved in antidepressant effects.

  2013cites this paper
• Blonanserin reverses the phencyclidine (PCP)-induced impairment in novel object recognition (NOR) in rats: role of indirect 5-HT(1A) partial agonism.

  2013cites this paper
• 5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons.

  2012influential citation
• S.11.02 Brain region-dependent internalisation of 5-HT1A receptors: molecular mechanisms and relevance for antidepressant therapy

  2012cites this paper
• Serotonin-1A Receptors and Cognitive Enhancement in Schizophrenia: Role for Brain Energy Metabolism

  2012cites this paper
• In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat

  2012cites this paper
• Transcriptional regulation of the 5-HT1A receptor: implications for mental illness

  2012cites this paper
• The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats

  2012cites this paper
• Cognitive Enhancers (Nootropics). Part 1: Drugs Interacting with Receptors

  2012cites this paper
• Biased agonism at serotonin 5-HT 1 A receptors : preferential postsynaptic activity for improved therapy of CNS disorders Practice points

  2011cites this paper
• Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties

  2011cites this paper